[Dysimmunologic and pseudolymphomatous adenopathies. I. Immunoblastic and plasmocytic lymphadenopathies].
The authors report 9 cases with pseudo-lymphomatous lesions associated with dysimmunitary features. They discuss the correlations between these cases and similar entities, for instance angio-immunoblastic lymphadenopathy (LAID). It seems that all these anatomoclinical syndromes could be referred to as dysimmunitary and pseudolymphomatous adenopathies (ADPL). The first type--ADPL type I--rich in immunoblasts and plasmocytes is defined. LAID is the most common form. The term "dysimmunitary" reflects not only the biological disturbances which accompany these lesions, but also their possible physiopathological mechanism, type I ADPL being apparently due to problem chiefly affecting humoral immunity.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001808:Blood Vessels / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology; D003937:Diagnosis, Differential; D004406:Dysgammaglobulinemia / Q000473:pathology; D005260:Female; D005455:Fluorescent Antibody Technique; D006644:Histiocytes / Q000473:pathology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000473:pathology*; D008099:Liver / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008206:Lymphatic Diseases / Q000276:immunology / Q000473:pathology*; D008207:Lymphatic Metastasis; D008214:Lymphocytes / Q000473:pathology*; D008297:Male; D008479:Mediastinal Neoplasms / Q000473:pathology; D008875:Middle Aged; D010950:Plasma Cells / Q000473:pathology*; D013154:Spleen / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology
Les adénopathies dysimmunitaires et pseudo-lymphomateuses. I. Lymphadénopathies immunoblastiques et plasmocytaires.